GeoVax Labs, Inc.

GOVX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-2.2M $-3.3M $-2.7M $-2.7M $-2.3M $-2.1M $-2.3M $-2.7M
Depreciation & Amortization $28.0K $28.8K $28.9K $69.0K $78.9K $93.6K $109.0K $119.8K
Depreciation — — — — — $73.7K $84.1K $94.9K
Amortization — — $0 $10.0K $10.0K $19.9K $24.9K —
Stock-Based Compensation $57.2K $967.7K $67.9K $479.1K $402.1K $310.1K $773.0K $750.5K
Net Cash from Operating Activities $-1.7M $-1.9M $-2.7M $-2.3M $-1.7M $-2.4M $-303.6K $-2.4M
Investing Activities
Capital Expenditures $4.4K — $15.9K $35.5K $86.6K — $11.9K $4.7K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-4.4K — $-15.9K $-35.5K $-86.6K — $-11.9K $874
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $1.6M $1.3M $2.7M $873.4K $3.3M $2.3M $404.4K $-430.4K
Net Change in Cash $-141.3K $-606.3K $-41.3K $-1.4M $1.5M $-132.1K $88.9K $-2.4M
Free Cash Flow $-1.7M — $-2.7M $-2.3M $-1.8M — $-315.5K $-2.4M
← Newer Page 2 of 3 Older →